Search Results - "de Masson, A"

Effectiveness and safety of mogamulizumab for the treatment of Sézary syndrome in very elderly patients: A real-world, multicentre, retrospective study conducted in France by Ribereau-Gayon, E, Beylot-Barry, M, De Masson, A, Ram-Wolff, C, Bagot, M, Pham-Ledard, A, Grange, F

Get full text

Dermatomyositis versus mycosis fungoides: Challenges in the diagnosis of erythroderma with associated myositis by Masson, A. de, Ram-Wolff, C., Bouaziz, J.D., Cayuela, J.M., Lorillon, G., Frumholtz, L., Cassius, C., Petit, A., Léonard-Louis, S., Battistella, M., Vignon-Pennamen, M.D., Rivet, J., Meignin, V., Duverger, L., Jachiet, M., Bagot, M., Lazaridou, I.

Get full text

Diversity and compartmentalization of Human Polyomavirus 7 in a patient with dyskeratotic dermatosis by Aboudar, S., Salmona, M., Masson, A., Rivet, J., Cardot‐Leccia, N., Mercier‐Delarue, S., Ram‐Wolff, C., Garnier, G., Bouaziz, J.‐D., Lebbé, C., Cavalie‐Meiffren, M., Le Goff, J., Bagot, M.

Get full text

New biotherapies for the treatment of cutaneous T-cell lymphomas by de Masson, A.

“…Most cutaneous lymphomas are cutaneous T-cell lymphomas, and the most common form is mycosis fungoides. Sézary syndrome is a leukemic form of cutaneous T-cell…”
Get full text

Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes by De Masson, A., Giustiniani, J., Marie-Cardine, A., Bouaziz, J. D., Dulphy, N., Gossot, D., Validire, P., Tazi, A., Garbar, C., Bagot, M., Merrouche, Y., Bensussan, A.

“…CD245 is a human surface antigen expressed on peripheral blood lymphocytes, initially delineated by two monoclonal antibodies DY12 and DY35. Until now, CD245…”
Get full text

Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients by Calugareanu, A., Jachiet, M., Tauber, M., Nosbaum, A., Aubin, F., Misery, L., Droitcourt, C., Barbarot, S., Debarbieux, S., Saussine, A., Bagot, M., de Masson, A., Sénéschal, J., Staumont‐Sallé, D., Bouaziz, J.‐D.

Get full text

Dramatic improvement of generalized prurigo nodularis with dupilumab by Calugareanu, A., Jachiet, M., Lepelletier, C., De Masson, A., Rybojad, M., Bagot, M., Bouaziz, J.D.

Get full text

Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry by Dobos, G., de Masson, A., Ram‐Wolff, C., Beylot‐Barry, M., Pham‐Ledard, A., Ortonne, N., Ingen‐Housz‐Oro, S., Battistella, M., d’Incan, M., Rouanet, J., Franck, F., Vignon‐Pennamen, M.D., Franck, N., Carlotti, A., Boulinguez, S., Lamant, L., Petrella, T., Dalac, S., Joly, P., Courville, P., Rivet, J., Dereure, O., Amatore, F., Taix, S., Grange, F., Durlach, A., Quéreux, G., Josselin, N., Moulonguet, I., Mortier, L., Dubois, R., Maubec, E., Laroche, L., Michel, L., Templier, I., Barete, S., Nardin, C., Augereau, O., Vergier, B., Bagot, M.

“…Summary Background Primary cutaneous lymphomas (PCLs) are a heterogeneous group of T‐cell (CTCL) and B‐cell (CBCL) malignancies. Little is known about their…”
Get full text

Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker by Roelens, M., Masson, A., Ram‐Wolff, C., Maki, G., Cayuela, J‐M., Marie‐Cardine, A., Bensussan, A., Toubert, A., Bagot, M., Moins‐Teisserenc, H.

“…Summary Background The early diagnosis of Sézary syndrome (SS) is challenging. Loss of CD7 and CD26 expression on CD4+ T cells is the currently used criterion…”
Get full text

Under‐representation of people of African ancestry in publications on the cutaneous manifestations of COVID‐19: coincidence or physiology? by Cassius, C, Frumholtz, L, Masson, A, Dadzie, O, Petit, A

Get full text

Association of autoimmunity and long‐term complete remission in patients with Sézary syndrome treated with mogamulizumab by Bonnet, P., Battistella, M., Roelens, M., Ram‐Wolff, C., Herms, F., Frumholtz, L., Bouaziz, J.‐D., Brice, P., Moins‐Teisserenc, H., Bagot, M., Masson, A.

Get full text

Identification of clonal skin myeloid cells by next‐generation sequencing in myelodysplasia cutis by Delaleu, J., Battistella, M., Rathana, K., Vignon‐Pennamen, M.‐D., Laurent, C., Ram‐Wolff, C., Fenaux, P., Jachiet, M., Zuelgaray, E., Bagot, M., Bouaziz, J.‐D., Masson, A.

Get full text

Effectiveness of brentuximab vedotin before and after allogeneic stem‐cell transplantation in the management of transformed mycosis fungoides by André, R., Ram‐Wolff, C., Battistella, M., Peffault de Latour, R., Petit, A., Bouaziz, J.D., Brice, P., Bagot, M., Masson, A.

Get full text

Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas by de Masson, A., Guitera, P., Brice, P., Moulonguet, I., Mouly, F., Bouaziz, J.-D., Battistella, M., Madelaine, I., Roux, J., Ram-Wolff, C., Cayuela, J.-M., Bachelez, H., Bensussan, A., Michel, L., Bagot, M.

“…Summary Background Alemtuzumab has been proposed as salvage therapy for refractory cutaneous T‐cell lymphomas (CTCLs). Long‐term follow‐up data are scarce…”
Get full text

Diagnostic performance of high‐throughput sequencing of the T‐cell receptor beta gene for the diagnosis of cutaneous T‐cell lymphoma by Zimmermann, C., Boisson, M., Ram‐Wolff, C., Sadoux, A., Louveau, B., Vignon‐Pennamen, M.‐D., Rivet, J., Cayuela, J.‐M., Dobos, G., Moins‐Teisserenc, H., Roelens, M., Gruber, A., Lebbé, C., Bagot, M., Battistella, M., Mourah, S., Masson, A.

“…The early diagnosis of cutaneous T-cell lymphomas (CTCL) may be challenging and based on a combination of clinical, biological, histological, and molecular…”
Get full text

Chronic graft‐versus‐host disease and inhibition of interleukin‐17: proof of concept in humans by Debureaux, P.‐E., Masson, A., Battistella, M., Fontbrune, F., Socié, G., Bouaziz, J.D., Michonneau, D.

“…Summary Psoriasiform chronic graft‐versus‐host disease (GvHD) is a rare clinical presentation recently described after allogeneic haematopoietic stem cell…”
Get full text

Recent advances on cutaneous lymphoma epidemiology by Dobos, G., Miladi, M., Michel, L., Ram-Wolff, C., Battistella, M., Bagot, M., de Masson, A.

“…Primary cutaneous lymphomas are a group of T- (CTCL) and B-cell (CBCL) malignancies. These diseases have different clinical presentations and prognosis. Our…”
Get full text

Lymph node and visceral progression without erythroderma or blood worsening in erythrodermic cutaneous T‐cell lymphoma: nine cases by Skayem, C., Beylot‐Barry, M., Masson, A., Dereure, O., Ram‐Wolff, C., Bagot, M., Vergier, B., Battistella, M., Ortonne, N., Ingen‐Housz‐Oro, S.

Get full text

Actinic cheilitis: a systematic review of treatment options by Trager, M.H., Farmer, K., Ulrich, C., Basset‐Seguin, N., Herms, F., Geskin, L.J., Bouaziz, J.‐D., Lebbé, C., Masson, A., Bagot, M., Dobos, G.

“…Actinic cheilitis is a premalignant condition that can progress to squamous cell carcinoma with a higher propensity for metastasis than cutaneous squamous cell…”
Get full text

Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas by Dumont, M., Ram‐Wolff, C., Roelens, M., Brice, P., Peffault de Latour, R., Battistella, M., Madelaine, I., Delyon, J., Herms, F., Bouaziz, J.‐D., Moins‐Teisserenc, H., Lebbé, C., Bagot, M., Masson, A.

Get full text